Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Research

Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer

Prostate Cancer and Prostatic Diseases volume 19, pages 298–304 (2016)Cite this article

Subjects

Abstract

Background:

Neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in patients with metastatic castration-resistant prostate cancer receiving systemic therapy. However, the prognostic significance of NLR was never previously evaluated in patients who underwent radical prostatectomy (RP) for prostate cancer. In the present study, we investigated the influence of NLR on survival after a RP for prostate cancer.

Methods:

We retrospectively reviewed clinical data of 2301 patients with prostate cancer who underwent RP at our institution between 2000 and 2010. Among these patients, we considered only patients who had a preoperative complete blood count with differential result available. Patients who received neoadjuvant or postoperative adjuvant treatment (radiation, androgen deprivation therapy or both) and those without adequate medical record were excluded. A Kaplan–Meier analysis was performed to analyze biochemical recurrence-free survival (BCRFS), overall survival (OS) and prostate cancer-specific survival (CSS). Univariate and multivariate Cox regression models were used for each end point.

Results:

In total, 2067 patients were evaluated; median follow-up time was 78 months (interquartile range (IQR) 65–96), median age at RP was 66 years (IQR 61–70) and median preoperative NLR was 1.76 (IQR 1.35–2.40). A Kaplan–Meier analysis showed a significant association between high NLR (⩾1.76) and decreased CSS (P=0.005) and OS (P=0.003) but not with BCRFS (P=0.223). In the univariate and multivariate regression analyses, a high NLR was a significant predictor of CSS (hazard ratio (HR) 2.012, 95% confidence interval (CI) 1.222–3.310, P=0.006) and OS (HR 1.650, 95% CI 1.127–2.416, P=0.010).

Conclusions:

This study shows that in patients with prostate cancer preoperative NLR is an independent prognostic factor for OS and CSS after a RP and suggests that a preoperative hematologic workup should be considered in the risk assessment of these patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Mantovani A, Romero P, Palucka AK, Marincola FM . Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 2008; 371: 771–783.

    Article  CAS  Google Scholar 

  2. Grivennikov SI, Greten FR, Karin M . Immunity, inflammation, and cancer. Cell 2010; 140: 883–899.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106: dju124.

    Article  PubMed  Google Scholar 

  4. Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M . Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol 2010; 184: 873–878.

    Article  PubMed  Google Scholar 

  5. An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 2010; 15: 516–522.

    Article  CAS  PubMed  Google Scholar 

  6. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009; 58: 15–23.

    Article  CAS  PubMed  Google Scholar 

  7. McMillan DC . An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 2008; 67: 257–262.

    Article  PubMed  Google Scholar 

  8. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS et al. A comparison of inflammation-based prognostic scores in patients with cancer. qA Glasgow Inflammation Outcome Study. Eur J Cancer 2011; 47: 2633–2641.

    Article  PubMed  Google Scholar 

  9. Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H et al. The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer 2012; 48: 202–208.

    Article  CAS  PubMed  Google Scholar 

  10. Lee SM, Russell A, Hellawell G . Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma. Korean J Urol 2015; 56: 749–755.

    Article  PubMed  PubMed Central  Google Scholar 

  11. van Soest RJ, Templeton AJ, Vera-Badillo FE, Mercier F, Sonpavde G, Amir E et al. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Ann Oncol 2015; 26: 743–749.

    Article  CAS  PubMed  Google Scholar 

  12. Templeton AJ, Pezaro C, Omlin A, McNamara MG, Leibowitz-Amit R, Vera-Badillo FE et al. Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer 2014; 120: 3346–3352.

    Article  CAS  PubMed  Google Scholar 

  13. Sonpavde G, Pond GR, Armstrong AJ, Clarke SJ, Vardy JL, Templeton AJ et al. Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer. Clin Genitourin Cancer 2014; 12: 317–324.

    Article  PubMed  Google Scholar 

  14. Shafique K, Proctor MJ, McMillan DC, Qureshi K, Leung H, Morrison DS . Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study. Prostate Cancer Prostatic Dis 2012; 15: 195–201.

    Article  CAS  PubMed  Google Scholar 

  15. Minardi D, Scartozzi M, Montesi L, Santoni M, Burattini L, Bianconi M et al. Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer. Springerplus 2015; 4: 255.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gazel E, Tastemur S, Acikgoz O, Yigman M, Olcucuoglu E, Camtosun A et al. Importance of neutrophil/lymphocyte ratio in prediction of PSA recurrence after radical prostatectomy. Asian Pac J Cancer Prev 2015; 16: 1813–1816.

    Article  PubMed  Google Scholar 

  17. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds.) AJCC Cancer Staging Manual, 7th ed. Springer: New York, 2010.

    Google Scholar 

  18. National Comprehensive Cancer Network (NCCN) clinical practice guidelinesin Oncology. Prostate cancer, version 1.2015. Available viahttp://www.nccn.org.

  19. Lee JY, Lee DH, Cho NH, Rha KH, Choi YD, Hong SJ et al. Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy. Yonsei Med J 2014; 55: 316–323.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lorente D, Mateo J, Templeton AJ, Zafeiriou Z, Bianchini D, Ferraldeschi R et al. Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use. Ann Oncol 2015; 26: 750–755.

    Article  CAS  PubMed  Google Scholar 

  21. Kwon YS, Han CS, Yu JW, Kim S, Modi P, Davis R et al. Neutrophil and lymphocyte counts as clinical markers for stratifying low-risk prostate cancer. Clin Genitourin Cancer 2015; 14: e1–e8.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Brandau S, Dumitru CA, Lang S . Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol 2013; 35: 163–176.

    Article  CAS  PubMed  Google Scholar 

  23. Langsenlehner T, Thurner EM, Krenn-Pilko S, Langsenlehner U, Stojakovic T, Gerger A et al. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol 2015; 33: 1661–1667.

    Article  CAS  PubMed  Google Scholar 

  24. Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007; 97: 1266–1270.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vesely MD, Schreiber RD . Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann NY Acad Sci 2013; 1284: 1–5.

    Article  CAS  PubMed  Google Scholar 

  26. Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW . The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 2011; 105: 93–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Nuhn P, Vaghasia AM, Goyal J, Zhou XC, Carducci MA, Eisenberger MA et al. Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel. BJU Int 2014; 114: E11–E17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003; 170: 2292–2295.

    Article  PubMed  Google Scholar 

  29. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 2006; 24: 3973–3978.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

    W S Jang, K S Cho, C Y Yoon, Y J Kang, J Y Lee, W S Ham, K H Rha, S J Hong & Y D Choi

  2. Department of Urology, Soonchunhyang University College of Medicine, Cheonan, Korea

    K H Kim

Authors
  1. W S Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K S Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K H Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Y Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y J Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Y Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W S Ham
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K H Rha
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S J Hong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Y D Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y D Choi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Prostate Cancer and Prostatic Diseases website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jang, W., Cho, K., Kim, K. et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio after radical prostatectomy in localized prostate cancer. Prostate Cancer Prostatic Dis 19, 298–304 (2016). https://doi.org/10.1038/pcan.2016.20

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2016.20

This article is cited by

Search

Advanced search

Quick links